According to a Science Magazine report, the first vaccine to cross the finish line might be only marginally effective, yet it could become the enemy of the good—or even the great—candidates in the wings by disrupting ongoing studies.
What’s the issue?In all likelihood, the U.S. Food and Drug Administration (FDA) or other regulators will issue the first COVID-19 vaccine approval or emergency use authorization (EUA) for one vaccine while many other candidates have clinical trials still underway or...
https://mfame.guru/first-covid-vaccine-approval-to-reduce-research-of-other-vaccines/